Reduced Estimated Glomerular Filtration Rate Is Associated with Stroke Outcome after Intravenous rt-PA: The Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA Registry
Authors:
Open Access
- 17 November 2010
- journal article
- research article
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 31 (2) , 123-129
Abstract
Background: The aim of this study was to determine whether renal dysfunction affects the outcome of stroke patients treated with recombinant tissue plasminogen activator (rt-PA). Methods: A retrospective, multicenter, observational study was conducted to identify the effects of underlying risk factors on intravenous rt-PA therapy using 0.6 mg/kg alteplase in 10 stroke centers in Japan. Consecutive stroke patients with a premorbid modified Rankin Scale (mRS) score ≤3 who received rt-PA were studied. Renal dysfunction was defined as estimated glomerular filtration rate (eGFR) 2 on admission. The outcome measures were any intracerebral hemorrhage (ICH) and symptomatic ICH within the initial 36 h; favorable (mRS 0–1) outcome, poor outcome (mRS 4–6) and mortality at 3 months. Results: Of a total of 578 patients (372 men; 64.4%, 71.4 ± 11.7 years old), renal dysfunction was present in 186 patients (32.2%). These patients were older and more commonly had hypertension, atrial fibrillation, prior ischemic heart disease and prior use of antithrombotic agents than patients without renal dysfunction. ICH (27.4 vs. 16.6%) and symptomatic ICH (8.1 vs. 2.6%) was more common in patients with renal dysfunction than in those without. At 3 months, patients with renal dysfunction had higher median mRS scores than those without (3 vs. 2). After multivariate adjustment for established outcome predictors, renal dysfunction was related to any ICH (odds ratio 1.81, 95% confidence interval 1.16–2.84), symptomatic ICH (2.64, 1.10–6.56), poor outcome (1.55, 1.01–2.38), and mortality (2.94, 1.38–6.42). Conclusions: Reduced eGFR was associated with early ICH and 3-month unfavorable outcome in stroke patients receiving intravenous rt-PA.Keywords
This publication has 18 references indexed in Scilit:
- Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortalityNephrology Dialysis Transplantation, 2008
- Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseasesJournal of Internal Medicine, 2006
- Impaired fibrinolytic activity in type II diabetes: Correlation with urinary albumin excretion and progression of renal diseaseKidney International, 2006
- Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama StudyKidney International, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC‐Norfolk) population studyJournal of Internal Medicine, 2004
- THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Traditional Cardiac Risk Factors in Individuals with Chronic Kidney DiseaseSeminars in Dialysis, 2003
- Systematic Review of Prognostic Models in Patients with Acute StrokeCerebrovascular Diseases, 2001
- Influence of hepatic and renal failure on pharmacokinetic properties of the novel recombinant plasminogen activator BM 06.022 in rats.Drug Metabolism and Disposition, 1993
- Turnover of Human Extrinsic (Tissue-Type) Plasminogen Activator in RabbitsThrombosis and Haemostasis, 1981